Cases

De-identified cases from verified clinicians — structured, searchable and open for peer input.

Share the medicine, never the patient. Every case passes a de-identification checklist and a patient-privacy scan before it's published. Ages are ranges, timing is relative.

No member cases yet

Be the first to share a de-identified case. The structured form and privacy checklist take about five minutes.

Sample cases from the preview

Dr. Michael Torres, MD

52mSports Medicine

Case study · Sports Medicine

Improving

Chronic lateral epicondylitis after failed conservative care

Age range: 40–49
Sex: Not stated
Presenting issue: Lateral elbow pain for 14 months, dominant arm. Failed 12 weeks of PT and two corticosteroid injections; symptoms returned within 6 weeks of each.
Approach: Single ultrasound-guided leukocyte-poor PRP injection with needle fenestration, then a progressive eccentric loading program.
Outcome: Pain 7/10 → 3/10 at week 8. Grip strength improving; back to full work duties.

Author asks: Second injection at week 12, or keep loading and reassess?

De-identified · author attested 2 images

Sofia Marchetti, DNP, FNP-C

1dWomen's Health

Case study · Women's Health

Seeking input

Perimenopause with vasomotor symptoms, poor sleep and new anxiety

Age range: 40–49
Sex: Female
Presenting issue: Eight months of hot flashes and night sweats, fragmented sleep, and new-onset anxiety. No prior psychiatric history. Thyroid function and CBC normal.
Approach: Transdermal estradiol with oral micronized progesterone at bedtime; CBT-I referral; sleep plan.
Outcome: Vasomotor symptoms down roughly 70% at week 10. Sleep improving; anxiety partly improved.

Author asks: Add an SSRI/SNRI now, or reassess at 16 weeks?

De-identified · moderator reviewed 1 document

Dr. Kevin Park, DO

2dTRT / Hormone Health

Case study · Hormone Health

Ongoing

Rising hematocrit three months into testosterone therapy

Age range: 50–59
Sex: Male
Presenting issue: Symptomatic low testosterone confirmed on two morning draws; started weekly injections. Hematocrit 53% at the three-month check.
Approach: Split to twice-weekly dosing at the same weekly total; hydration counselling; sleep apnea screening; repeat labs at six weeks.
Outcome: Hematocrit 50% at six weeks. Sleep study pending.

Author asks: At what hematocrit do you pause therapy rather than adjust dosing?

De-identified · author attested